Retatrutide 40mg Pen

£150.00

⚠️ This is a research-only compound. Not approved for clinical or human use.

Shipping 14-28 Days

Description

Retatrutide is an investigational triple agonist compound that simultaneously targets GIP, GLP-1, and glucagon receptors. It is being explored in research for its potential in treating obesity and metabolic disorders. This compound is experimental and intended for research use only.

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “Retatrutide 40mg Pen”

Your email address will not be published. Required fields are marked *